DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DR REDDYS
02 1AET PHARMA
03 1ACTAVIS LABS FL INC
04 1AMNEAL
05 1ASPIRO
06 1AUROBINDO PHARMA
07 1BIOCON PHARMA
08 1ENDO OPERATIONS
09 1EUGIA PHARMA
10 1FRESENIUS KABI USA
11 1GLAND PHARMA LTD
12 1HETERO LABS LTD III
13 1HIKMA
14 1I 3 PHARMS
15 2MERCK SHARP DOHME
16 1MSD MERCK CO
17 1MYLAN LABS LTD
18 2SCHERING
19 1SINOTHERAPEUTICS INC
20 1SPECGX LLC
21 1WESTMINSTER PHARMS
01 1FOR SUSPENSION, DELAYED RELEASE;ORAL
02 7SOLUTION;INTRAVENOUS
03 1SUSPENSION; ORAL
04 2SUSPENSION;ORAL
05 12TABLET, DELAYED RELEASE;ORAL
01 2DISCN
02 20RX
03 1Blank
01 4NOXAFIL
02 1NOXAFIL POWDERMIX KIT
03 18POSACONAZOLE
01 18No
02 4Yes
03 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Approval Date : 2022-04-07
Application Number : 212500
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
RLD : No
TE Code : AB
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Approval Date : 2021-02-01
Application Number : 213454
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Approval Date : 2022-11-30
Application Number : 207355
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : AB
Brand Name : NOXAFIL
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Approval Date : 2006-09-15
Application Number : 22003
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD :
TE Code :
Brand Name : NOXAFIL
Dosage Form : SUSPENSION; ORAL
Dosage Strength : 40MG/ML
Approval Date :
Application Number : 22027
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AP
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Approval Date : 2023-12-26
Application Number : 209983
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AB
Brand Name : POSACONAZOLE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Approval Date : 2020-05-15
Application Number : 208773
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code :
Brand Name : NOXAFIL
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2013-11-25
Application Number : 205053
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code : AP
Brand Name : NOXAFIL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Approval Date : 2014-03-13
Application Number : 205596
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : No
TE Code : AP
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Approval Date : 2022-05-25
Application Number : 208768
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
